Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Baxter
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Sulodexide


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Sulodexide?

Sulodexide is an investigational drug.

There have been 18 clinical trials for Sulodexide. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2005.

The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Arterial Occlusive Diseases. The leading clinical trial sponsors are Collaborative Study Group (CSG), Keryx Biopharmaceuticals, and Alfasigma S.p.A.

Recent Clinical Trials for Sulodexide
TitleSponsorPhase
Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower ExtremitiesAlfasigma S.p.A.Phase 3
Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower ExtremitiesValue Outcomes Ltd.Phase 3
Sulodexide, VESSELĀ®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)Arianna Anticoagulazione FoundationPhase 3

See all Sulodexide clinical trials

Clinical Trial Summary for Sulodexide

Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide

See all Sulodexide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Baxter
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.